Crossref
Summary for Patients: Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations
Annals of Internal Medicine · 2024
DOI: 10.7326/p24-0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Internal Medicine, 2024. Hauptthemen laut MEDLINE: Metformin, Pregnancy Trimester, First, Hypoglycemic Agents, Abnormalities, Drug-Induced.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
MetforminPregnancy Trimester, FirstHypoglycemic AgentsAbnormalities, Drug-InducedHumansPregnancyFemaleRisk FactorsInfant, Newborn
Substanzen
MetforminHypoglycemic Agents
Zitieren
APA
(2024). Summary for Patients: Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations. Annals of Internal Medicine. https://doi.org/10.7326/p24-0002
Vancouver
Summary for Patients: Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations. Annals of Internal Medicine. 2024. doi:10.7326/p24-0002
BibTeX
@article{euvimed2024,
title = {Summary for Patients: Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations},
journal = {Annals of Internal Medicine},
year = {2024},
doi = {10.7326/p24-0002}
}
EUVIMED